Prediction of small-for-gestational-age neonates: Screening by biophysical and biochemical markers at 30-34 weeks

Ultrasound in Obstetrics and Gynecology

Volumn 46, Issue 4, 2015, Pages 446-451

  Bakalis, S ^a   Peeva, G ^a   Gonzalez, R ^a   Poon, L C ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

mean arterial pressure; placental growth factor; pre eclampsia; pyramid of antenatal care; small for gestational age; soluble fms like tyrosine kinase 1; third trimester screening; uterine artery pulsatility index

Indexed keywords

BIOLOGICAL MARKER; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTERIAL PRESSURE; BIOMETRY; BIRTH WEIGHT; BLOOD; ECHOGRAPHY; FEMALE; FETAL GROWTH RETARDATION; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; MALE; METABOLISM; NEWBORN; PHYSIOLOGY; PREDICTIVE VALUE; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROCEDURES; PROSPECTIVE STUDY; PULSED DOPPLER ULTRASONOGRAPHY; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY; UTERINE ARTERY;

ADULT; ARTERIAL PRESSURE; BIOMARKERS; BIOMETRY; BIRTH WEIGHT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, THIRD; PRENATAL CARE; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, PULSED; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84942981739     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14863     Document Type: Article

References (28)

1. Lindqvist PG, Molin J,. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25: 258-264.
2. Bais JMJ, Eskes M, Pel M, Bonsel GJ, Bleker OP,. Effectiveness of detection of intrauterine retardation by abdominal palpation as screening test in a low-risk population: an observational study. Eur J Obstet Gynecol Reprod Biol 2004; 116: 164-169.
3. Lindhard A, Nielsen PV, Mouritsen LA, Zachariassen A, Sørensen HU, Rosenø H,. The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 675-680.
4. Bakalis S, Silva M, Akolekar R, Poon LC, Nicolaides KH,. Prediction of small-for-gestational-age neonates: screening by fetal biometry at 30-34 weeks. Ultrasound Obstet Gynecol 2015; 45: 551-558.
5. Bakalis S, Stoilov B, Akolekar R, Poon LC, Nicolaides KH,. Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks. Ultrasound Obstet Gynecol 2015; 45: 707-714.
6. Bakalis S, Gallo DM, Mendez O, Poon LC, Nicolaides KH,. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks. Ultrasound Obstet Gynecol 2015; 46: 208-215.
7. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH,. One-stage screening for pregnancy complications by color doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96: 559-564.
8. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH,. Protocol for measurement of mean arterial pressure at 11-13 weeks' gestation. Fetal Diagn Ther 2012; 31: 42-48.
9. Robinson HP, Fleming JE,. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
10. Snijders RJ, Nicolaides KH,. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-48.
11. Poon LCY, Volpe N, Muto B, Syngelaki A, Nicolaides KH,. Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012; 32: 156-165.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 19-24.
13. Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH,. Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 689-697.
14. Wright A, Wright D, Ispas A, Poon LC, Nicolaides KH,. Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 698-706.
15. Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH,. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 591-598.
16. Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH,. Serum sFlt-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015; 45: 584-590.
17. Severi F, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P, Zagonari S, Pilu G,. Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2002; 19: 225-228.
18. Ghosh G, Gudmundsson S,. Uterine and umbilical artery Doppler are comparable in predicting perinatal outcome of growth-restricted fetuses. BJOG 2009; 116: 424-430.
19. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH,. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006; 195: 1668-1673.
20. Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE,. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008; 102: 146-151.
21. Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacõs E,. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303-309.
22. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R,. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-13.
23. Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N,. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. European Journal Obstet Gynecol Reprod Biol 2013; 171: 225-230.
24. Herraiz I, Dröge A, GõmeZ-Montes E, Wolfgang H, Galindo A, Stefan V,. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol 2014: 124: 265-273.
25. Nicolaides KH,. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183-196.
26. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y,. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414.
27. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E,. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141-146.
28. Yu CK, Papageorghiou AT, Parra M, Palma DR, Nicolaides KH,. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 233-239.